SFX by Ex Libris Inc.

Title:	Molecular Diversity of the Dopamine Receptors
Source:	Annual Review of Pharmacology and Toxicology [0362-1642] Civelli, O yr:1993

Basic

Full text

Full text available via Annual Reviews

Year:

Volume:

Issue:

Start Page:

Full text available via Annual Reviews Back Volume Collection

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Giros, B. "Alternative splicing directs the expression of two D2 dopamine receptor isoforms." Nature 342.6252 (1989): 923-926.
description	2.	Ehringer, H. "Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system." Parkinsonism & related disorders 4.2 (1998): 53-7.
description	3.	Ellenbroek, B A A. "Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs." Pharmacology & therapeutics 57.1 (1993): 1-78.
description	4.	Gingrich, J A A. "Recent advances in the molecular biology of dopamine receptors." Annual review of neuroscience 16.1 (1993): 299-321.
description	5.	Kerbeshian, L. "A clinical pharmacological approach to treating Tourette Syndrome in children and adolescents." Neuroscience and biobehavioral reviews 12.3-4 (1988): 241-5.
description	6.	Locke, J. "Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease." Neuroscience Letters 439.2 (2008): 129-133.
description	7.	Sandor, P. "Pharmacological management of tics in patients with TS." Journal of psychosomatic research 55.1: 41-48.
description	8.	Jomphe, C. "Expression of D2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function." Neuropharmacology 50.5 (2006): 595-605.
description	9.	Farooqui SM, C. "Production and characterization of a monoclonal antibody to dopamine D2 receptor: comparison with a polyclonal antibody to a different epitope." Biochemical and biophysical research communications 184.2 (1992): 661-667.
description	10.	Monsma, Frederick J. "Multiple D2 dopamine receptors produced by alternative RNA splicing." Nature 342.6252 (1989): 926-929.
description	11.	Ortore, G. "A theoretical study to investigate D2DAR/D4DAR selectivity: Receptor modeling and molecular docking of dopaminergic ligands." Journal of medicinal chemistry 49.4 (2006): 1397-1407.
description	12.	Van Tol, H H H. "Multiple dopamine D4 receptor variants in the human population." Nature 358.6382 (1992): 149-52.
description	13.	Kreitzer, Anatol C C. "Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models." Nature 445.7128 (2007): 643-7.
description	14.	Needham, P L. "P-4-15 Zotepine: Preclinical tests predict antipsychotic efficacy and an atypical profile." European neuropsychopharmacology 5.3 (1995): 331-332.
description	15.	Blin, O. "A comparative review of new antipsychotics." Canadian Journal of Psychiatry 44.3 (1999): 235-244.
description	16.	Muly, Murat C. "Distribution of D1 and D5 dopamine receptors in the primate and rat basolateral amygdala." Brain Structure and Function 213.4-5 (2009): 375-393.
description	17.	Desbonnet, L. "Mice mutant for genes associated with schizophrenia: Common phenotype or distinct endophenotypes?" Behavioural Brain Research 204.2 (2009): 258-273.
description	18.	Joshua, B. "Disorders of Attention or Learning in Neurodevelopmental Disorders." Seminars in pediatric neurology 12.4 (2005): 229-241.
description	19.	Jaber, M. "Dopamine receptors and brain function." Neuropharmacology 35.11 (1996): 1503-19.
description	20.	BARUCH, I. "Differential Performance of Acute and Chronic Schizophrenics in a Latent Inhibition Task." Journal of nervous and mental disease 176.10 (1988): 598-606.